Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2026-03-03 @ 4:26 AM
Study NCT ID:
NCT04187833
Status:
COMPLETED
Last Update Posted:
2025-01-14
First Post:
2019-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes
Sponsor:
Case Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-13
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-02
First Submit QC Date:
None
Study First Post Date:
2019-12-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-17
Results First Submit QC Date:
None
Results First Post Date:
2025-01-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-13
Last Update Post Date:
2025-01-14
Last Update Post Date Type:
ACTUAL